Catalyst = News of phase II (positive results) of revolutionary treatment(insulin mouthwash) for DMII. This has more favorable results than Metformin, the conventional preferred treatment. BMY owns Metformin, which is trading over 44.00/share...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.